Blinatumomab-Ponatinib Salvage Therapy in B-Cell Acute Lymphoblastic Leukemia: Case Report of Benefit

Patients with B-ALL may benefit from sequential treatment with CD19 CAR-T therapy and anti-CD19 bispecific T-cell engager therapy regardless of sequence, according to a case study report.

from Latest articles from Cancer Therapy Advisor Hematologic Cancers http://bit.ly/2ROEld8